Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at Redeye Fight Cancer Seminar
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – September 2022
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at SEB Healthcare Seminar 2022
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight initiates pre-clinical studies with uTREAT[®] therapy in head and neck cancer (HNSCC) and neuroendocrine tumors (NET)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Transaction with shares in Curasight A/S made by managerial employee
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – June 2022
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Recruitment completed in uPAR-PET study in brain cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Transaction with shares in Curasight A/S made by managerial employee